Get SEC filing alerts via email and in your feed for VERU INC.
VERU
VERU INC.
About VERU INC.
Veru Inc. is a biopharmaceutical company focused on developing and commercializing medicines for metabolic diseases, oncology, and ARDS. Its core assets include late-stage drug candidates enobosarm and sabizabulin, targeting obesity, breast cancer, and viral-induced lung injury. The company also markets the FDA-approved FC2 Female Condom, serving global sexual health markets and public health sectors. Its business model combines drug development, clinical trials, and health product sales.
This description was generated via AI from an annual report.
Updated 8 months ago.